{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:40:26Z","timestamp":1792690826840,"version":"4.5.0"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and\nMedical Research Council","doi-asserted-by":"publisher","award":["CRE-CP"],"award-info":[{"award-number":["CRE-CP"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1007\/s40272-019-00344-8","type":"journal-article","created":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T22:02:48Z","timestamp":1561932168000},"page":"261-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":200,"title":["Botulinum Toxin in the Management of Children\nwith Cerebral Palsy"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7976-3243","authenticated-orcid":false,"given":"Iqbal","family":"Multani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3455-6790","authenticated-orcid":false,"given":"Jamil","family":"Manji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9001-1410","authenticated-orcid":false,"given":"Tandy","family":"Hastings-Ison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7910-4766","authenticated-orcid":false,"given":"Abhay","family":"Khot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6607-7631","authenticated-orcid":false,"given":"Kerr","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"issue":"4","key":"344_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/01241398-199307000-00013","volume":"13","author":"LA Koman","year":"1993","unstructured":"Koman LA, Mooney JF 3rd, Smith B, Goodman A, Mulvaney T. Management\nof cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr\nOrthop. 1993;13(4):489\u201395.","journal-title":"J Pediatr Orthop"},{"issue":"5","key":"344_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1469-8749.1994.tb11864.x","volume":"36","author":"AP Cosgrove","year":"1994","unstructured":"Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management\nof the lower limb in cerebral palsy. Dev Med Child Neurol.\n1994;36(5):386\u201396.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"344_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0966-6362(99)00054-5","volume":"11","author":"HK Graham","year":"2000","unstructured":"Graham HK, Aoki KR, Autti-Ramo I, Boyd RN, Delgado MR,\nGaebler-Spira DJ, et al. Recommendations for the use of botulinum toxin type A\nin the management of cerebral palsy. Gait Posture.\n2000;11(1):67\u201379.","journal-title":"Gait Posture."},{"issue":"5\u20136","key":"344_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejpn.2006.08.006","volume":"10","author":"F Heinen","year":"2006","unstructured":"Heinen F, Molenaers G, Fairhurst C, Carr LJ, Desloovere K, Chaleat\nValayer E, et al. European consensus table\u00a02006 on botulinum toxin for children\nwith cerebral palsy. Eur J Paediatr Neurol.\n2006;10(5\u20136):215\u201325.","journal-title":"Eur J Paediatr Neurol."},{"issue":"1","key":"344_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejpn.2009.09.005","volume":"14","author":"F Heinen","year":"2010","unstructured":"Heinen F, Desloovere K, Schroeder AS, Berweck S, Borggraefe I, van\nCampenhout A, et al. The updated European Consensus 2009 on the use of botulinum\ntoxin for children with cerebral palsy. Eur J Paediatr Neurol.\n2010;14(1):45\u201366.","journal-title":"Eur J Paediatr Neurol."},{"issue":"Suppl. 2","key":"344_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1468-1331.2010.03126.x","volume":"17","author":"SC Love","year":"2010","unstructured":"Love SC, Novak I, Kentish M, Desloovere K, Heinen F, Molenaers G,\net al. Botulinum toxin assessment, intervention and after-care for lower limb\nspasticity in children with cerebral palsy: international consensus statement.\nEur J Neurol. 2010;17(Suppl. 2):9\u201337.","journal-title":"Eur J Neurol"},{"key":"344_CR7","unstructured":"Multani I, Manji J, Tang MJ, Howard J, Graham HK. Sarcopenia,\nbotulinum toxin A and cerebral palsy. J Bone Jt Surg Am. 2019. (in press)."},{"issue":"10","key":"344_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1017\/S0012162205001453","volume":"47","author":"M Gough","year":"2005","unstructured":"Gough M, Fairhurst C, Shortland AP. Botulinum toxin and cerebral\npalsy: time for reflection? Dev Med Child Neurol.\n2005;47(10):709\u201312.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"344_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1469-8749.1997.tb07408.x","volume":"39","author":"IS Corry","year":"1997","unstructured":"Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum\ntoxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child\nNeurol. 1997;39(3):185\u201393.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"344_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1067\/mpd.2000.108393","volume":"137","author":"D Fehlings","year":"2000","unstructured":"Fehlings D, Rang M, Glazier J, Steele C. An evaluation of\nbotulinum-A toxin injections to improve upper extremity function in children\nwith hemiplegic cerebral palsy. J Pediatr. 2000;137(3):331\u20137.","journal-title":"J Pediatr"},{"issue":"1","key":"344_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jpeds.2014.01.050","volume":"165","author":"L Copeland","year":"2014","unstructured":"Copeland L, Edwards P, Thorley M, Donaghey S, Gascoigne-Pees L,\nKentish M, et al. Botulinum toxin A for nonambulatory children with cerebral\npalsy: a double blind randomized controlled trial. J Pediatr.\n2014;165(1):140\u201346.e4.","journal-title":"J Pediatr."},{"issue":"4","key":"344_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1469-8749.2012.04438.x","volume":"55","author":"TW Pin","year":"2013","unstructured":"Pin TW, Elmasry J, Lewis J. Efficacy of botulinum toxin A in\nchildren with cerebral palsy in gross motor function classification system\nlevels IV and V: a systematic review. Dev Med Child Neurol.\n2013;55(4):304\u201313.","journal-title":"Dev Med Child Neurol"},{"issue":"9404","key":"344_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0140-6736(03)15351-2","volume":"363","author":"S Berweck","year":"2004","unstructured":"Berweck S, Schroeder AS, Fietzek UM, Heinen F. Sonography-guided\ninjection of botulinum toxin in children with cerebral palsy. Lancet.\n2004;363(9404):249\u201350.","journal-title":"Lancet"},{"issue":"6","key":"344_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1469-8749.2011.03913.x","volume":"53","author":"L Barber","year":"2011","unstructured":"Barber L, Hastings-Ison T, Baker R, Barrett R, Lichtwark G. Medial\ngastrocnemius muscle volume and fascicle length in children aged 2 to 5\u00a0years\nwith cerebral palsy. Dev Med Child Neurol. 2011;53(6):543\u20138.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"344_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gaitpost.2003.08.010","volume":"20","author":"NR Fry","year":"2004","unstructured":"Fry NR, Gough M, Shortland AP. Three-dimensional realisation of\nmuscle morphology and architecture using ultrasound. Gait Posture.\n2004;20(2):177\u201382.","journal-title":"Gait Posture."},{"issue":"Suppl. 2","key":"344_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1468-1331.2010.03127.x","volume":"17","author":"D Fehlings","year":"2010","unstructured":"Fehlings D, Novak I, Berweck S, Hoare B, Stott NS, Russo RN, et al.\nBotulinum toxin assessment, intervention and follow-up for paediatric upper limb\nhypertonicity: international consensus statement. Eur J Neurol. 2010;17(Suppl.\n2):38\u201356.","journal-title":"Eur J Neurol"},{"issue":"1","key":"344_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MOP.0000000000000567","volume":"30","author":"NJ Nahm","year":"2018","unstructured":"Nahm NJ, Graham HK, Gormley ME Jr, Georgiadis AG. Management of\nhypertonia in cerebral palsy. Curr Opin Pediatr.\n2018;30(1):57\u201364.","journal-title":"Curr Opin Pediatr"},{"issue":"8","key":"344_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.27072","volume":"32","author":"J Jankovic","year":"2017","unstructured":"Jankovic J. Botulinum toxin: state of the art. Mov Disord.\n2017;32(8):1131\u20138.","journal-title":"Mov Disord"},{"key":"344_CR19","doi-asserted-by":"publisher","first-page":"15082","DOI":"10.1038\/nrdp.2015.82","volume":"2","author":"HK Graham","year":"2016","unstructured":"Graham HK, Rosenbaum P, Paneth N, Dan B, Lin JP, Damiano DL, et al.\nCerebral palsy. Nat Rev Dis Primers. 2016;2:15082.","journal-title":"Nat Rev Dis Primers."},{"issue":"1","key":"344_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/jama.2010.1937","volume":"305","author":"A Albanese","year":"2011","unstructured":"Albanese A. Terminology for preparations of botulinum neurotoxins:\nwhat a difference a name makes. JAMA. 2011;305(1):89\u201390.","journal-title":"JAMA"},{"key":"344_CR21","first-page":"8","volume":"109","author":"P Rosenbaum","year":"2007","unstructured":"Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et\nal. A report: the definition and classification of cerebral palsy April 2006.\nDev Med Child Neurol Suppl. 2007;109:8\u201314.","journal-title":"Dev Med Child Neurol Suppl"},{"key":"344_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/B978-1-4160-4928-9.00014-7","volume-title":"Botulinum toxin: therapeutic clinical practice and science","author":"J Leonard","year":"2009","unstructured":"Leonard J, Graham H. Treatment of motor disorders in cerebral palsy\nwith botulinum neurotoxin. In: Jankovic J, Albanese A, Atassi MZ, Dolly JO,\nHallett M, Mayer NH, editors. Botulinum toxin: therapeutic clinical practice and\nscience. Philadelphia: Saunders Elsevier; 2009. p. 172\u201391."},{"issue":"2","key":"344_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1302\/0301-620X.85B2.14066","volume":"85","author":"HK Graham","year":"2003","unstructured":"Graham HK, Selber P. Musculoskeletal aspects of cerebral palsy. J\nBone Jt Surg Br. 2003;85(2):157\u201366.","journal-title":"J Bone Jt Surg Br"},{"key":"344_CR24","first-page":"484","volume-title":"Lovell and Winter\u2019s pediatric orthopaedics","author":"HK Graham","year":"2014","unstructured":"Graham HK, Thomason PNTF. Cerebral palsy. In: Weinstein SL, Ponseti\nIVJM, editors. Lovell and Winter\u2019s pediatric orthopaedics. 7th ed. Philadelphia:\nWolters Kluwer Health\/Lippincott Williams & Wilkins; 2014. p.\n484\u2013554.","edition":"7"},{"issue":"6","key":"344_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1469-8749.2012.04229.x","volume":"54","author":"M Gough","year":"2012","unstructured":"Gough M, Shortland AP. Could muscle deformity in children with\nspastic cerebral palsy be related to an impairment of muscle growth and altered\nadaptation? Dev Med Child Neurol. 2012;54(6):495\u20139.","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"344_CR26","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1469-8749.2010.03686.x","volume":"52","author":"RS Barrett","year":"2010","unstructured":"Barrett RS, Lichtwark GA. Gross muscle morphology and structure in\nspastic cerebral palsy: a systematic review. Dev Med Child Neurol.\n2010;52(9):794\u2013804.","journal-title":"Dev Med Child Neurol"},{"issue":"12","key":"344_CR27","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1469-8749.2000.tb00695.x","volume":"42","author":"C Cans","year":"2000","unstructured":"Cans C. Surveillance of cerebral palsy in Europe: a collaboration\nof cerebral palsy surveys and registers. Dev Med Child Neurol.\n2000;42(12):816\u201324.","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"344_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1469-8749.1997.tb07414.x","volume":"39","author":"R Palisano","year":"1997","unstructured":"Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B.\nDevelopment and reliability of a system to classify gross motor function in\nchildren with cerebral palsy. Dev Med Child Neurol.\n1997;39(4):214\u201323.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"344_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1469-8749.2010.03843.x","volume":"53","author":"JP Lin","year":"2011","unstructured":"Lin JP. The contribution of spasticity to the movement disorder of\ncerebral palsy using pathway analysis: does spasticity matter? Dev Med Child\nNeurol. 2011;53(1):7\u20139.","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"344_CR30","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/mds.23088","volume":"25","author":"TD Sanger","year":"2010","unstructured":"Sanger TD, Chen D, Fehlings DL, Hallett M, Lang AE, Mink JW, et al.\nDefinition and classification of hyperkinetic movements in childhood. Mov\nDisord. 2010;25(11):1538\u201349.","journal-title":"Mov Disord"},{"issue":"9\u201310","key":"344_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1440-1754.2005.00687.x","volume":"41","author":"J Howard","year":"2005","unstructured":"Howard J, Soo B, Graham HK, Boyd RN, Reid S, Lanigan A, et al.\nCerebral palsy in Victoria: motor types, topography and gross motor function. J\nPaediatr Child Health. 2005;41(9\u201310):479\u201383.","journal-title":"J Paediatr Child Health"},{"issue":"1\u20132","key":"344_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/09638280400014576","volume":"27","author":"AD Pandyan","year":"2005","unstructured":"Pandyan AD, Gregoric M, Barnes MP, Wood D, Van Wijck F, Burridge J,\net al. Spasticity: clinical perceptions, neurological realities and meaningful\nmeasurement. Disabil Rehabil. 2005;27(1\u20132):2\u20136.","journal-title":"Disabil Rehabil"},{"issue":"5","key":"344_CR33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1469-8749.1994.tb11863.x","volume":"36","author":"AP Cosgrove","year":"1994","unstructured":"Cosgrove AP, Graham HK. Botulinum toxin A prevents the development\nof contractures in the hereditary spastic mouse. Dev Med Child Neurol.\n1994;36(5):379\u201385.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"344_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/dmcn.12551","volume":"57","author":"V Schiariti","year":"2015","unstructured":"Schiariti V, Selb M, Cieza A, O\u2019Donnell M. International\nclassification of functioning, disability and Health core sets for children and\nyouth with cerebral palsy: a consensus meeting. Dev Med Child Neurol.\n2015;57(2):149\u201358.","journal-title":"Dev Med Child Neurol"},{"key":"344_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2474-9-44","volume":"9","author":"A Mutlu","year":"2008","unstructured":"Mutlu A, Livanelioglu A, Gunel MK. Reliability of Ashworth and\nModified Ashworth scales in children with spastic cerebral palsy. BMC\nMusculoskelet Disord. 2008;9:44.","journal-title":"BMC Musculoskelet Disord."},{"issue":"12","key":"344_CR36","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1177\/7010.2006.00222","volume":"21","author":"WK Yam","year":"2006","unstructured":"Yam WK, Leung MS. Interrater reliability of Modified Ashworth Scale\nand Modified Tardieu Scale in children with spastic cerebral palsy. J Child\nNeurol. 2006;21(12):1031\u20135.","journal-title":"J Child Neurol"},{"issue":"3","key":"344_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.apmr.2009.11.017","volume":"91","author":"JM Gracies","year":"2010","unstructured":"Gracies JM, Burke K, Clegg NJ, Browne R, Rushing C, Fehlings D, et\nal. Reliability of the Tardieu Scale for assessing spasticity in children with\ncerebral palsy. Arch Phys Med Rehabil. 2010;91(3):421\u20138.","journal-title":"Arch Phys Med Rehabil"},{"issue":"15","key":"344_CR38","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/09638280500404305","volume":"28","author":"AB Haugh","year":"2006","unstructured":"Haugh AB, Pandyan AD, Johnson GR. A systematic review of the\nTardieu Scale for the measurement of spasticity. Disabil Rehabil.\n2006;28(15):899\u2013907.","journal-title":"Disabil Rehabil"},{"issue":"10","key":"344_CR39","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/dmcn.12419","volume":"56","author":"L Bar-On","year":"2014","unstructured":"Bar-On L, Aertbelien E, Molenaers G, Dan B, Desloovere K. Manually\ncontrolled instrumented spasticity assessments: a systematic review of\npsychometric properties. Dev Med Child Neurol.\n2014;56(10):932\u201350.","journal-title":"Dev Med Child Neurol"},{"issue":"1\u20132","key":"344_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/09638280400014683","volume":"27","author":"DE Wood","year":"2005","unstructured":"Wood DE, Burridge JH, van Wijck FM, McFadden C, Hitchcock RA,\nPandyan AD, et al. Biomechanical approaches applied to the lower and upper limb\nfor the measurement of spasticity: a systematic review of the literature.\nDisabil Rehabil. 2005;27(1\u20132):19\u201332.","journal-title":"Disabil Rehabil"},{"issue":"2","key":"344_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1017\/S0012162200000220","volume":"42","author":"S Barwood","year":"2000","unstructured":"Barwood S, Baillieu C, Boyd R, Brereton K, Low J, Nattrass G, et\nal. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled\nclinical trial. Dev Med Child Neurol. 2000;42(2):116\u201321.","journal-title":"Dev Med Child Neurol"},{"key":"344_CR42","first-page":"287","volume-title":"Cerebral palsy: science and clinical practice","author":"P Thomason","year":"2014","unstructured":"Thomason P, Willoughby K, Graham HK. Orthopaedic assessment. In:\nDan B, Paneth N, Rosenbloom L, editors. Cerebral palsy: science and clinical\npractice. London: Mac Keith Press; 2014. p. 287\u2013312."},{"issue":"4","key":"344_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/dmcn.12276","volume":"56","author":"T Hastings-Ison","year":"2014","unstructured":"Hastings-Ison T, Blackburn C, Opie NL, Graham HK, Rawicki B, Wolfe\nR, et al. Reproducibility of an instrumented measure for passive ankle\ndorsiflexion in conscious and anaesthetized children with cerebral palsy. Dev\nMed Child Neurol. 2014;56(4):378\u201385.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"344_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/000841749606300103","volume":"63","author":"M Law","year":"1996","unstructured":"Law M, Cooper B, Strong S, Stewart D, Rigby P, Letts L. The\nperson-environment-occupation model: a transactive approach to occupational\nperformance. Can J Occup Ther. 1996;63(1):9\u201323.","journal-title":"Can J Occup Ther"},{"issue":"Suppl 4","key":"344_CR45","first-page":"51-S7","volume":"6","author":"G Molenaers","year":"1999","unstructured":"Molenaers G, Desloovere K, Eyssen M, Decat J, Jonkers I, De Cock P.\nBotulinum toxin type A treatment of cerebral palsy: an integrated approach. Eur\nJ Neurol. 1999;6(Suppl 4):51-S7.","journal-title":"Eur J Neurol"},{"issue":"1","key":"344_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/dmcn.13205","volume":"59","author":"SA Rethlefsen","year":"2017","unstructured":"Rethlefsen SA, Blumstein G, Kay RM, Dorey F, Wren TA. Prevalence of\nspecific gait abnormalities in children with cerebral palsy revisited: influence\nof age, prior surgery, and Gross Motor Function Classification System level. Dev\nMed Child Neurol. 2017;59(1):79\u201388.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"344_CR47","first-page":"79","volume":"25","author":"TA Wren","year":"2005","unstructured":"Wren TA, Rethlefsen S, Kay RM. Prevalence of specific gait\nabnormalities in children with cerebral palsy: influence of cerebral palsy\nsubtype, age, and previous surgery. J Pediatr Orthop.\n2005;25(1):79\u201383.","journal-title":"J Pediatr Orthop"},{"issue":"5","key":"344_CR48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11832-013-0511-x","volume":"7","author":"G Molenaers","year":"2013","unstructured":"Molenaers G, Fagard K, Van Campenhout A, Desloovere K. Botulinum\ntoxin A treatment of the lower extremities in children with cerebral palsy. J\nChild Orthop. 2013;7(5):383\u20137.","journal-title":"J Child Orthop"},{"issue":"3","key":"344_CR49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01241398-199405000-00005","volume":"14","author":"LA Koman","year":"1994","unstructured":"Koman LA, Mooney JF 3rd, Smith BP, Goodman A, Mulvaney T.\nManagement of spasticity in cerebral palsy with botulinum-A toxin: report of a\npreliminary, randomized, double-blind trial. J Pediatr Orthop.\n1994;14(3):299\u2013303.","journal-title":"J Pediatr Orthop"},{"issue":"3","key":"344_CR50","first-page":"304","volume":"18","author":"IS Corry","year":"1998","unstructured":"Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK.\nBotulinum toxin A compared with stretching casts in the treatment of spastic\nequinus: a randomised prospective trial. J Pediatr Orthop.\n1998;18(3):304\u201311.","journal-title":"J Pediatr Orthop"},{"issue":"1","key":"344_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1469-8749.2003.tb00852.x","volume":"45","author":"AH Mackey","year":"2003","unstructured":"Mackey AH, Lobb GL, Walt SE, Stott NS. Reliability and validity of\nthe Observational Gait Scale in children with spastic diplegia. Dev Med Child\nNeurol. 2003;45(1):4\u201311.","journal-title":"Dev Med Child Neurol"},{"key":"344_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ridd.2017.07.002","volume":"68","author":"FA Read","year":"2017","unstructured":"Read FA, Boyd RN, Barber LA. Longitudinal assessment of gait\nquality in children with bilateral cerebral palsy following repeated lower limb\nintramuscular botulinum toxin-A injections. Res Dev Disabil.\n2017;68:35\u201341.","journal-title":"Res Dev Disabil"},{"issue":"3","key":"344_CR53","first-page":"296","volume":"23","author":"HS Read","year":"2003","unstructured":"Read HS, Hazlewood ME, Hillman SJ, Prescott RJ, Robb JE. Edinburgh\nvisual gait score for use in cerebral palsy. J Pediatr Orthop.\n2003;23(3):296\u2013301.","journal-title":"J Pediatr Orthop"},{"issue":"1","key":"344_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0966-6362(99)00012-0","volume":"10","author":"DH Sutherland","year":"1999","unstructured":"Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ.\nDouble-blind study of botulinum A toxin injections into the gastrocnemius muscle\nin patients with cerebral palsy. Gait Posture. 1999;10(1):1\u20139.","journal-title":"Gait Posture."},{"issue":"3","key":"344_CR55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.gaitpost.2009.05.020","volume":"30","author":"R Baker","year":"2009","unstructured":"Baker R, McGinley JL, Schwartz MH, Beynon S, Rozumalski A, Graham\nHK, et al. The gait profile score and movement analysis profile. Gait Posture.\n2009;30(3):265\u20139.","journal-title":"Gait Posture."},{"issue":"4","key":"344_CR56","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1302\/1863-2548.12.180044","volume":"12","author":"T Hastings-Ison","year":"2018","unstructured":"Hastings-Ison T, Sangeux M, Thomason P, Rawicki B, Fahey M, Graham\nHK. Onabotulinum toxin-A (Botox) for spastic equinus in cerebral palsy: a\nprospective kinematic study. J Child Orthop. 2018;12(4):390\u20137.","journal-title":"J Child Orthop"},{"key":"344_CR57","volume-title":"Gross motor function measure (GMFM-66 & GMFM-88) user\u2019s manual","author":"DJ Russell","year":"2002","unstructured":"Russell DJ, Rosenbaum PL, Wright M, Avery LM. Gross motor function\nmeasure (GMFM-66 & GMFM-88) user\u2019s manual. 3rd ed. London: Mac Keith Press;\n2002.","edition":"3"},{"issue":"12","key":"344_CR58","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.1469-8749.2002.tb00772.x","volume":"44","author":"DS Reddihough","year":"2002","unstructured":"Reddihough DS, King JA, Coleman GJ, Fosang A, McCoy AT, Thomason P,\net al. Functional outcome of botulinum toxin A injections to the lower limbs in\ncerebral palsy. Dev Med Child Neurol. 2002;44(12):820\u20137.","journal-title":"Dev Med Child Neurol"},{"issue":"12","key":"344_CR59","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.apmr.2006.08.342","volume":"87","author":"VA Scholtes","year":"2006","unstructured":"Scholtes VA, Dallmeijer AJ, Knol DL, Speth LA, Maathuis CG,\nJongerius PH. The combined effect of lower-limb multilevel Botulinum Toxin A and\ncomprehensive rehabiliation on mobility in children with cerebral palsy: a\nrandomised clinical trial. Arch Phys Med Rehabil.\n2006;87(12):1551\u20138.","journal-title":"Arch Phys Med Rehabil"},{"issue":"6","key":"344_CR60","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1017\/S0012162206000934","volume":"48","author":"RJ Palisano","year":"2006","unstructured":"Palisano RJ, Cameron D, Rosenbaum PL, Walter SD, Russell D.\nStability of the gross motor function classification system. Dev Med Child\nNeurol. 2006;48(6):424\u20138.","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"344_CR61","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1440-1754.2007.01122.x","volume":"43","author":"K Howell","year":"2007","unstructured":"Howell K, Selber P, Graham HK, Reddihough D. Botulinum neurotoxin\nA: an unusual systemic effect. J Paediatr Child Health.\n2007;43(6):499\u2013501.","journal-title":"J Paediatr Child Health"},{"issue":"11","key":"344_CR62","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1001\/jama.1991.03460110084029","volume":"265","author":"AL Albright","year":"1991","unstructured":"Albright AL, Cervi A, Singletary J. Intrathecal baclofen for\nspasticity in cerebral palsy. JAMA. 1991;265(11):1418\u201322.","journal-title":"JAMA"},{"issue":"10","key":"344_CR63","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1017\/S0012162206001745","volume":"48","author":"UG Narayanan","year":"2006","unstructured":"Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K.\nInitial development and validation of the Caregiver Priorities and Child Health\nIndex of Life with Disabilities (CPCHILD). Dev Med Child Neurol.\n2006;48(10):804\u201312.","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"344_CR64","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1017\/S0012162206001162","volume":"48","author":"AC Eliasson","year":"2006","unstructured":"Eliasson AC, Krumlinde-Sundholm L, Rosblad B, Beckung E, Arner M,\nOhrvall AM, et al. The Manual Ability Classification System (MACS) for children\nwith cerebral palsy: scale development and evidence of validity and reliability.\nDev Med Child Neurol. 2006;48(7):549\u201354.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"344_CR65","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2106\/00004623-198163020-00006","volume":"63","author":"JH House","year":"1981","unstructured":"House JH, Gwathmey FW, Fidler MO. A dynamic approach to the\nthumb-in palm deformity in cerebral palsy. J Bone Jt Surg Am.\n1981;63(2):216\u201325.","journal-title":"J Bone Jt Surg Am"},{"issue":"5","key":"344_CR66","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/09638280903171469","volume":"32","author":"K Klingels","year":"2010","unstructured":"Klingels K, De Cock P, Molenaers G, Desloovere K, Huenaerts C,\nJaspers E, et al. Upper limb motor and sensory impairments in children with\nhemiplegic cerebral palsy. Can they be measured reliably? Disabil Rehabil.\n2010;32(5):409\u201316.","journal-title":"Disabil Rehabil."},{"issue":"5","key":"344_CR67","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s11999-011-2065-x","volume":"470","author":"LV Wagner","year":"2012","unstructured":"Wagner LV, Davids JR. Assessment tools and classification systems\nused for the upper extremity in children with cerebral palsy. Clin Orthop Relat\nRes. 2012;470(5):1257\u201371.","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"344_CR68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/adc.85.4.275","volume":"85","author":"JH Patrick","year":"2001","unstructured":"Patrick JH, Roberts AP, Cole GF. Therapeutic choices in the\nlocomotor management of the child with cerebral palsy\u2014more luck than judgement?\nArch Dis Child. 2001;85(4):275\u20139.","journal-title":"Arch Dis Child"},{"issue":"4","key":"344_CR69","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1212\/WNL.0b013e3181cbcd2f","volume":"74","author":"MR Delgado","year":"2010","unstructured":"Delgado MR, Hirtz D, Aisen M, Ashwal S, Fehlings DL, McLaughlin J,\net al. Practice parameter: pharmacologic treatment of spasticity in children and\nadolescents with cerebral palsy (an evidence-based review): report of the\nQuality Standards Subcommittee of the American Academy of Neurology and the\nPractice Committee of the Child Neurology Society. Neurology.\n2010;74(4):336\u201343.","journal-title":"Neurology."},{"issue":"1","key":"344_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2005.05.001","volume":"34","author":"A Verrotti","year":"2006","unstructured":"Verrotti A, Greco R, Spalice A, Chiarelli F, Iannetti P.\nPharmacotherapy of spasticity in children with cerebral palsy. Pediatr Neurol.\n2006;34(1):1\u20136.","journal-title":"Pediatr Neurol"},{"issue":"12","key":"344_CR71","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/dmcn.13532","volume":"59","author":"R Masson","year":"2017","unstructured":"Masson R, Pagliano E, Baranello G. Efficacy of oral pharmacological\ntreatments in dyskinetic cerebral palsy: a systematic review. Dev Med Child\nNeurol. 2017;59(12):1237\u201348.","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl. 1","key":"344_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0883073896011001S01","volume":"11","author":"AL Albright","year":"1996","unstructured":"Albright AL. Spasticity and movement disorders in cerebral palsy. J\nChild Neurol. 1996;11(Suppl. 1):1\u20134.","journal-title":"J Child Neurol"},{"issue":"2","key":"344_CR73","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/0883073815587030","volume":"31","author":"AI Dai","year":"2016","unstructured":"Dai AI, Aksoy SN, Demiryurek AT. Comparison of efficacy and side\neffects of oral baclofen versus tizanidine therapy with adjuvant botulinum toxin\ntype A in children with cerebral palsy and spastic equinus foot deformity. J\nChild Neurol. 2016;31(2):184\u20139.","journal-title":"J Child Neurol"},{"issue":"12","key":"344_CR74","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1177\/0883073808319074","volume":"23","author":"AI Dai","year":"2008","unstructured":"Dai AI, Wasay M, Awan S. Botulinum toxin type A with oral baclofen\nversus oral tizanidine: a nonrandomized pilot comparison in patients with\ncerebral palsy and spastic equinus foot deformity. J Child Neurol.\n2008;23(12):1464\u20136.","journal-title":"J Child Neurol"},{"issue":"7","key":"344_CR75","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.apmr.2003.09.032","volume":"85","author":"JL Gooch","year":"2004","unstructured":"Gooch JL, Patton CP. Combining botulinum toxin and phenol to manage\nspasticity in children. Arch Phys Med Rehabil.\n2004;85(7):1121\u20134.","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"344_CR76","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/dmcn.14005","volume":"61","author":"AI Buizer","year":"2019","unstructured":"Buizer AI, Martens BHM, van Ravenhorst GC, Schoonmade LJ, Becher\nJG, Vermeulen RJ. Effect of continuous intrathecal baclofen therapy in children:\na systematic review. Dev Med Child Neurol. 2019;61(2):128\u201334.","journal-title":"Dev Med Child Neurol."},{"issue":"8","key":"344_CR77","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S1474-4422(09)70151-6","volume":"8","author":"M Vidailhet","year":"2009","unstructured":"Vidailhet M, Yelnik J, Lagrange C, Fraix V, Grabli D, Thobois S, et\nal. Bilateral pallidal deep brain stimulation for the treatment of patients with\ndystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet\nNeurol. 2009;8(8):709\u201317.","journal-title":"Lancet Neurol."},{"issue":"4","key":"344_CR78","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11832-008-0105-1","volume":"2","author":"A Khot","year":"2008","unstructured":"Khot A, Sloan S, Desai S, Harvey A, Wolfe R, Graham HK. Adductor\nrelease and chemodenervation in children with cerebral palsy: a pilot study in\n16 children. J Child Orthop. 2008;2(4):293\u20139.","journal-title":"J Child Orthop"},{"issue":"Suppl. 1","key":"344_CR79","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/0883073896011001S04","volume":"11","author":"LA Koman","year":"1996","unstructured":"Koman LA, Mooney JF 3rd, Smith BP. Neuromuscular blockade in the\nmanagement of cerebral palsy. J Child Neurol. 1996;11(Suppl.\n1):23\u20138.","journal-title":"J Child Neurol"},{"key":"344_CR80","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","volume":"79","author":"M Montal","year":"2010","unstructured":"Montal M. Botulinum neurotoxin: a marvel of protein design. Annu\nRev Biochem. 2010;79:591\u2013617.","journal-title":"Annu Rev Biochem"},{"key":"344_CR81","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.toxicon.2017.08.014","volume":"147","author":"A Cocco","year":"2018","unstructured":"Cocco A, Albanese A. Recent developments in clinical trials of\nbotulinum neurotoxins. Toxicon. 2018;147:77\u201383.","journal-title":"Toxicon"},{"issue":"19","key":"344_CR82","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1212\/01.wnl.0000311391.00944.c4","volume":"70","author":"DM Simpson","year":"2008","unstructured":"Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman\nB, et al. Assessment: botulinum neurotoxin for the treatment of spasticity (an\nevidence-based review): report of the Therapeutics and Technology Assessment\nSubcommittee of the American Academy of Neurology. Neurology.\n2008;70(19):1691\u20138.","journal-title":"Neurology."},{"issue":"6","key":"344_CR83","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","volume":"96","author":"A de Paiva","year":"1999","unstructured":"de Paiva A, Meunier FA, Molgo J, Aoki KR, Dolly JO. Functional\nrepair of motor endplates after botulinum neurotoxin type A poisoning: biphasic\nswitch of synaptic activity between nerve sprouts and their parent terminals.\nProc Natl Acad Sci USA. 1999;96(6):3200\u20135.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5","key":"344_CR84","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/dsu.12125","volume":"39","author":"IK Koerte","year":"2013","unstructured":"Koerte IK, Schroeder AS, Fietzek UM, Borggraefe I, Kerscher M,\nBerweck S, et al. Muscle atrophy beyond the clinical effect after a single dose\nof OnabotulinumtoxinA injected in the procerus muscle: a study with magnetic\nresonance imaging. Dermatol Surg. 2013;39(5):761\u20135.","journal-title":"Dermatol Surg"},{"issue":"10","key":"344_CR85","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/mds.22661","volume":"24","author":"AS Schroeder","year":"2009","unstructured":"Schroeder AS, Ertl-Wagner B, Britsch S, Schroder JM, Nikolin S,\nWeis J, et al. Muscle biopsy substantiates long-term MRI alterations one year\nafter a single dose of botulinum toxin injected into the lateral gastrocnemius\nmuscle of healthy volunteers. Mov Disord.\n2009;24(10):1494\u2013503.","journal-title":"Mov Disord"},{"issue":"3","key":"344_CR86","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1302\/0301-620X.83B3.0830364","volume":"83","author":"DC Borton","year":"2001","unstructured":"Borton DC, Walker K, Pirpiris M, Nattrass GR, Graham HK. Isolated\ncalf lengthening in cerebral palsy. Outcome analysis of risk factors. J Bone Jt\nSurg Br. 2001;83(3):364\u201370.","journal-title":"J Bone Jt Surg Br."},{"issue":"10","key":"344_CR87","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2106\/JBJS.K.01542","volume":"95","author":"GB Firth","year":"2013","unstructured":"Firth GB, Passmore E, Sangeux M, Thomason P, Rodda J, Donath S, et\nal. Multilevel surgery for equinus gait in children with spastic diplegic\ncerebral palsy: medium-term follow-up with gait analysis. J Bone Jt Surg Am.\n2013;95(10):931\u20138.","journal-title":"J Bone Jt Surg Am"},{"issue":"5","key":"344_CR88","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2106\/JBJS.J.00410","volume":"93","author":"P Thomason","year":"2011","unstructured":"Thomason P, Baker R, Dodd K, Taylor N, Selber P, Wolfe R, et al.\nSingle-event multilevel surgery in children with spastic diplegia: a pilot\nrandomized controlled trial. J Bone Jt Surg Am.\n2011;93(5):451\u201360.","journal-title":"J Bone Jt Surg Am"},{"issue":"Suppl. 4","key":"344_CR89","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1468-1331.1999.tb00031.x","volume":"6","author":"RN Boyd","year":"1999","unstructured":"Boyd RN, Graham HK. Objective measurement of clinical findings in\nthe use of botulinum toxin type A for the management of children with cerebral\npalsy. Eur J Neurol. 1999;6(Suppl. 4):23\u201335.","journal-title":"Eur J Neurol"},{"issue":"10","key":"344_CR90","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1469-8749.2002.tb00268.x","volume":"44","author":"R Baker","year":"2002","unstructured":"Baker R, Jasinski M, Maciag-Tymecka I, Michalowska-Mrozek J,\nBonikowski M, Carr L, et al. Botulinum toxin treatment of spasticity in diplegic\ncerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging\nstudy. Dev Med Child Neurol. 2002;44(10):666\u201375.","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"344_CR91","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1469-8749.2008.03264.x","volume":"51","author":"P Kanovsky","year":"2009","unstructured":"Kanovsky P, Bares M, Severa S, Richardson A, Dysport Paediatric\nLimb Spasticity Study G. Long-term efficacy and tolerability of 4-monthly versus\nyearly botulinum toxin type A treatment for lower-limb spasticity in children\nwith cerebral palsy. Dev Med Child Neurol. 2009;51(6):436\u201345.","journal-title":"Dev Med Child Neurol."},{"issue":"7","key":"344_CR92","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/dmcn.12962","volume":"58","author":"T Hastings-Ison","year":"2016","unstructured":"Hastings-Ison T, Blackburn C, Rawicki B, Fahey M, Simpson P, Baker\nR, et al. Injection frequency of botulinum toxin A for spastic equinus: a\nrandomized clinical trial. Dev Med Child Neurol.\n2016;58(7):750\u20137.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"344_CR93","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jbiomech.2010.08.020","volume":"44","author":"R Fortuna","year":"2011","unstructured":"Fortuna R, Vaz MA, Youssef AR, Longino D, Herzog W. Changes in\ncontractile properties of muscles receiving repeat injections of botulinum toxin\n(Botox). J Biomech. 2011;44(1):39\u201344.","journal-title":"J Biomech"},{"issue":"4","key":"344_CR94","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/mus.24576","volume":"52","author":"VB Minamoto","year":"2015","unstructured":"Minamoto VB, Suzuki KP, Bremner SN, Lieber RL, Ward SR. Dramatic\nchanges in muscle contractile and structural properties after 2 botulinum toxin\ninjections. Muscle Nerve. 2015;52(4):649\u201357.","journal-title":"Muscle Nerve"},{"issue":"3","key":"344_CR95","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.bpo.0000150819.72608.86","volume":"25","author":"TY Chin","year":"2005","unstructured":"Chin TY, Nattrass GR, Selber P, Graham HK. Accuracy of\nintramuscular injection of botulinum toxin A in juvenile cerebral palsy: a\ncomparison between manual needle placement and placement guided by electrical\nstimulation. J Pediatr Orthop. 2005;25(3):286\u201391.","journal-title":"J Pediatr Orthop"},{"issue":"4","key":"344_CR96","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1017\/S0012162299000493","volume":"41","author":"NW Eames","year":"1999","unstructured":"Eames NW, Baker R, Hill N, Graham K, Taylor T, Cosgrove A. The\neffect of botulinum toxin A on gastrocnemius length: magnitude and duration of\nresponse. Dev Med Child Neurol. 1999;41(4):226\u201332.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"344_CR97","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0966-6362(99)00037-5","volume":"10","author":"IS Corry","year":"1999","unstructured":"Corry IS, Cosgrove AP, Duffy CM, Taylor TC, Graham HK. Botulinum\ntoxin A in hamstring spasticity. Gait Posture.\n1999;10(3):206\u201310.","journal-title":"Gait Posture."},{"issue":"9","key":"344_CR98","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1469-8749.1998.tb15428.x","volume":"40","author":"NS Thompson","year":"1998","unstructured":"Thompson NS, Baker RJ, Cosgrove AP, Corry IS, Graham HK.\nMusculoskeletal modelling in determining the effect of botulinum toxin on the\nhamstrings of patients with crouch gait. Dev Med Child Neurol.\n1998;40(9):622\u20135.","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl. 5","key":"344_CR99","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1468-1331.2001.00040.x","volume":"8","author":"K Desloovere","year":"2001","unstructured":"Desloovere K, Molenaers G, Jonkers I, De Cat J, De Borre L, Nijs J,\net al. A randomized study of combined botulinum toxin type A and casting in the\nambulant child with cerebral palsy using objective outcome measures. Eur J\nNeurol. 2001;8(Suppl. 5):75\u201387.","journal-title":"Eur J Neurol"},{"issue":"1","key":"344_CR100","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4172\/2329-6895.1000109","volume":"1","author":"AMO Bakheit","year":"2013","unstructured":"Bakheit AMO. Botulinum toxin as a stand-alone treatment for muscle\nspasticity: review of the evidence. J Neurol Disord.\n2013;1(1):109.","journal-title":"J Neurol Disord."},{"issue":"Suppl. 5","key":"344_CR101","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1468-1331.2001.00043.x","volume":"8","author":"RN Boyd","year":"2001","unstructured":"Boyd RN, Dobson F, Parrott J, Love S, Oates J, Larson A, et al. The\neffect of botulinum toxin type A and a variable hip abduction orthosis on gross\nmotor function: a randomized controlled trial. Eur J Neurol. 2001;8(Suppl.\n5):109\u201319.","journal-title":"Eur J Neurol"},{"issue":"1","key":"344_CR102","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2106\/JBJS.F.01416","volume":"90","author":"HK Graham","year":"2008","unstructured":"Graham HK, Boyd R, Carlin JB, Dobson F, Lowe K, Nattrass G, et al.\nDoes botulinum toxin a combined with bracing prevent hip displacement in\nchildren with cerebral palsy and \u201chips at risk\u201d? A randomized, controlled trial.\nJ Bone Jt Surg Am. 2008;90(1):23\u201333.","journal-title":"J Bone Jt Surg Am"},{"issue":"8","key":"344_CR103","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1469-8749.2012.04340.x","volume":"54","author":"K Willoughby","year":"2012","unstructured":"Willoughby K, Ang SG, Thomason P, Graham HK. The impact of\nbotulinum toxin A and abduction bracing on long-term hip development in children\nwith cerebral palsy. Dev Med Child Neurol. 2012;54(8):743\u20137.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"344_CR104","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1469-8749.2009.03583.x","volume":"52","author":"K Naidu","year":"2010","unstructured":"Naidu K, Smith K, Sheedy M, Adair B, Yu X, Graham HK. Systemic\nadverse events following botulinum toxin A therapy in children with cerebral\npalsy. Dev Med Child Neurol. 2010;52(2):139\u201344.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"344_CR105","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/dmcn.13286","volume":"59","author":"J Montastruc","year":"2017","unstructured":"Montastruc J, Marque P, Moulis F, Bourg V, Lambert V, Durrieu G, et\nal. Adverse drug reactions of botulinum neurotoxin type A in children with\ncerebral palsy: a pharmaco-epidemiological study in VigiBase. Dev Med Child\nNeurol. 2017;59(3):329\u201334.","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"344_CR106","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1469-8749.2009.03315.x","volume":"51","author":"CT Lundy","year":"2009","unstructured":"Lundy CT, Doherty GM, Fairhurst CB. Botulinum toxin type A\ninjections can be an effective treatment for pain in children with hip spasms\nand cerebral palsy. Dev Med Child Neurol. 2009;51(9):705\u201310.","journal-title":"Dev Med Child Neurol"},{"key":"344_CR107","unstructured":"Graham HK. Unpublished data. 2019."},{"issue":"3","key":"344_CR108","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/dmcn.14088","volume":"61","author":"K Ostojic","year":"2019","unstructured":"Ostojic K, Paget SP, Morrow AM. Management of pain in children and\nadolescents with cerebral palsy: a systematic review. Dev Med Child Neurol.\n2019;61(3):315\u201321.","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl. 5","key":"344_CR109","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1046\/j.1468-1331.2001.00048.x","volume":"8","author":"RN Boyd","year":"2001","unstructured":"Boyd RN, Morris ME, Graham HK. Management of upper limb dysfunction\nin children with cerebral palsy: a systematic review. Eur J Neurol.\n2001;8(Suppl. 5):150\u201366.","journal-title":"Eur J Neurol"},{"issue":"1","key":"344_CR110","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1542\/peds.2013-0675","volume":"133","author":"L Sakzewski","year":"2014","unstructured":"Sakzewski L, Ziviani J, Boyd RN. Efficacy of upper limb therapies\nfor unilateral cerebral palsy: a meta-analysis. Pediatrics.\n2014;133(1):e175\u2013204.","journal-title":"Pediatrics"},{"issue":"6","key":"344_CR111","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01202412-200511000-00001","volume":"14","author":"TY Chin","year":"2005","unstructured":"Chin TY, Duncan JA, Johnstone BR, Graham HK. Management of the\nupper limb in cerebral palsy. J Pediatr Orthop B.\n2005;14(6):389\u2013404.","journal-title":"J Pediatr Orthop B"},{"issue":"1","key":"344_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apmr.2006.10.017","volume":"88","author":"M Wallen","year":"2007","unstructured":"Wallen M, O\u2019Flaherty SJ, Waugh MC. Functional outcomes of\nintramuscular botulinum toxin type a and occupational therapy in the upper limbs\nof children with cerebral palsy: a randomized controlled trial. Arch Phys Med\nRehabil. 2007;88(1):1\u201310.","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"344_CR113","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1469-8749.2009.03387.x","volume":"52","author":"CA Olesch","year":"2010","unstructured":"Olesch CA, Greaves S, Imms C, Reid SM, Graham HK. Repeat botulinum\ntoxin-A injections in the upper limb of children with hemiplegia: a randomized\ncontrolled trial. Dev Med Child Neurol. 2010;52(1):79\u201386.","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"344_CR114","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1017\/S0012162205000903","volume":"47","author":"LA Speth","year":"2005","unstructured":"Speth LA, Leffers P, Janssen-Potten YJ, Vles JS. Botulinum toxin A\nand upper limb functional skills in hemiparetic cerebral palsy: a randomized\ntrial in children receiving intensive therapy. Dev Med Child Neurol.\n2005;47(7):468\u201373.","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"344_CR115","doi-asserted-by":"publisher","first-page":"389","DOI":"10.5014\/ajot.58.4.389","volume":"58","author":"BJ Hoare","year":"2004","unstructured":"Hoare BJ, Imms C. Upper-limb injections of botulinum toxin-A in\nchildren with cerebral palsy: a critical review of the literature and clinical\nimplications for occupational therapists. Am J Occup Ther.\n2004;58(4):389\u201397.","journal-title":"Am J Occup Ther"},{"issue":"7","key":"344_CR116","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2106\/JBJS.M.01577","volume":"97","author":"AE Van Heest","year":"2015","unstructured":"Van Heest AE, Bagley A, Molitor F, James MA. Tendon transfer\nsurgery in upper-extremity cerebral palsy is more effective than botulinum toxin\ninjections or regular, ongoing therapy. J Bone Jt Surg Am.\n2015;97(7):529\u201336.","journal-title":"J Bone Jt Surg Am"},{"key":"344_CR117","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.toxicon.2018.01.017","volume":"147","author":"Y Safarpour","year":"2018","unstructured":"Safarpour Y, Jabbari B. Botulinum toxin treatment of pain\nsyndromes\u2014an evidence based review. Toxicon. 2018;147:120\u20138.","journal-title":"Toxicon"},{"issue":"3","key":"344_CR118","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1651-2227.2009.01626.x","volume":"99","author":"KN Parkinson","year":"2010","unstructured":"Parkinson KN, Gibson L, Dickinson HO, Colver AF. Pain in children\nwith cerebral palsy: a cross-sectional multicentre European study. Acta\nPaediatr. 2010;99(3):446\u201351.","journal-title":"Acta Paediatr"},{"key":"344_CR119","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14145","author":"E Will","year":"2019","unstructured":"Will E, Magill N, Arnold R, Davies M, Doherty G, Fairhurst C, et\nal. Preoperative botulinum neurotoxin A for children with bilateral cerebral\npalsy undergoing major hip surgery: a randomized double-blind placebo-controlled\ntrial. Dev Med Child Neurol. 2019;. \n                  https:\/\/doi.org\/10.1111\/dmcn.14145\n                  \n                .","journal-title":"Dev Med Child Neurol."},{"issue":"5","key":"344_CR120","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/WNF.0b013e31804b1a0d","volume":"30","author":"BE Crowner","year":"2007","unstructured":"Crowner BE, Brunstrom JE, Racette BA. Iatrogenic botulism due to\ntherapeutic botulinum toxin a injection in a pediatric patient. Clin\nNeuropharmacol. 2007;30(5):310\u20133.","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"344_CR121","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/WNF.0b013e31815cba8a","volume":"31","author":"N Roche","year":"2008","unstructured":"Roche N, Schnitzler A, Genet FF, Durand MC, Bensmail D. Undesirable\ndistant effects following botulinum toxin type a injection. Clin Neuropharmacol.\n2008;31(5):272\u201380.","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"344_CR122","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1469-8749.2010.03814.x","volume":"53","author":"SJ O\u2019Flaherty","year":"2011","unstructured":"O\u2019Flaherty SJ, Janakan V, Morrow AM, Scheinberg AM, Waugh MC.\nAdverse events and health status following botulinum toxin type A injections in\nchildren with cerebral palsy. Dev Med Child Neurol.\n2011;53(2):125\u201330.","journal-title":"Dev Med Child Neurol"},{"issue":"14","key":"344_CR123","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/j.jbiomech.2013.07.028","volume":"46","author":"R Fortuna","year":"2013","unstructured":"Fortuna R, Horisberger M, Vaz MA, Herzog W. Do skeletal muscle\nproperties recover following repeat onabotulinum toxin A injections? J Biomech.\n2013;46(14):2426\u201333.","journal-title":"J Biomech"},{"issue":"11","key":"344_CR124","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/dmcn.13988","volume":"60","author":"C Alexander","year":"2018","unstructured":"Alexander C, Elliott C, Valentine J, Stannage K, Bear N, Donnelly\nCJ, et al. Muscle volume alterations after first botulinum neurotoxin A\ntreatment in children with cerebral palsy: a 6-month prospective cohort study.\nDev Med Child Neurol. 2018;60(11):1165\u201371.","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"344_CR125","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/dmcn.12200","volume":"55","author":"SA Williams","year":"2013","unstructured":"Williams SA, Reid S, Elliott C, Shipman P, Valentine J. Muscle\nvolume alterations in spastic muscles immediately following botulinum toxin\ntype-A treatment in children with cerebral palsy. Dev Med Child Neurol.\n2013;55(9):813\u201320.","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"344_CR126","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/dmcn.14056","volume":"61","author":"SH Schless","year":"2019","unstructured":"Schless SH, Cenni F, Bar-On L, Hanssen B, Kalkman B, O\u2019Brien T, et\nal. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A\ninterventions in children with spastic cerebral palsy. Dev Med Child Neurol.\n2019;61(7):783\u201390. \n                  https:\/\/doi.org\/10.1111\/dmcn.14056\n                  \n                .","journal-title":"Dev Med Child Neurol."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00344-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-019-00344-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00344-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T10:13:35Z","timestamp":1597140815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-019-00344-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":126,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8,1]]}},"alternative-id":["344"],"URL":"https:\/\/doi.org\/10.1007\/s40272-019-00344-8","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"1 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Kerr Graham received non-financial support from the National Health\nand Medical Research Council of Australia (NHMRC) Centre of Research Excellence\nin Cerebral Palsy (CRE-CP). None of the authors received financial support for\nthe publication of this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Iqbal Multani declares no conflict of interest. Jamil Manji\ndeclares no conflict of interest. Tandy Hastings-Ison declares no conflict of\ninterest. Abhay Khot declares no conflict of interest. Kerr Graham declares no\nconflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}